Literature DB >> 2892019

Monoclonal anti-CD4 in arthritis.

C Herzog, C Walker, W Pichler, A Aeschlimann, P Wassmer, H Stockinger, W Knapp, P Rieber, W Müller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892019     DOI: 10.1016/s0140-6736(87)91158-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  32 in total

Review 1.  Immunotherapy of rheumatoid arthritis.

Authors:  R A Watts; J D Isaacs
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

Review 2.  Approaches toward peptide-based immunotherapy of autoimmune diseases.

Authors:  L Adorini; J C Guéry; S Trembleau
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  Regulation of immunity by anti-T-cell antibodies.

Authors:  D Wofsy
Journal:  West J Med       Date:  1990-09

Review 4.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 5.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

6.  Production of erythrocyte autoantibodies in NZB mice is inhibited by CD4 antibodies.

Authors:  G G Oliveira; P R Hutchings; I M Roitt; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Synovial fluid antigen-presenting cell function in rheumatoid arthritis.

Authors:  N J Viner; J S Gaston; P A Bacon
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma.

Authors:  R O Williams; D G Williams; M Feldmann; R N Maini
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  The effects of mesoporphyrin on experimental arthritis in mice.

Authors:  H Nagai; Y Takaoka; H Mori; N Matsuura
Journal:  Inflamm Res       Date:  1996-06       Impact factor: 4.575

Review 10.  New perspectives of secondary and tertiary therapy for rheumatoid arthritis.

Authors:  R F Willkens
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.